• Company
• It is expected that the SGLT-2 combination will be activated
• by Eo, Yun-Ho Nov 8, 2021 05:52am

• Policy
• "Reference pricing will activate sales of generic drugs"
• by Lee, Jeong-Hwan Nov 8, 2021 05:51am

• Policy
• Will RWD drive accessibility to ultra-high-priced drugs?
• by Kim, Jung-Ju Nov 8, 2021 05:51am

• Company
• K-Rare Disease Drug Hunterase that is more popular overseas
• by Chon, Seung-Hyun Nov 8, 2021 05:51am

• Policy
• The introduction of a double price system is empty talk
• by Lee, Jeong-Hwan Nov 8, 2021 05:51am

• Company
• Reimbursement for Olumiant in AD is being discussed
• by Eo, Yun-Ho Nov 5, 2021 05:24am

• Policy
• Taiwanese PharmaEssentia got a business license
• by Lee, Tak-Sun Nov 5, 2021 05:24am

• Company
• LG Chem, developing a new drug that has never existed before
• by Lee, Seok-Jun Nov 5, 2021 05:24am

• Opinion
• [Reporter’s View] New drugs for Alzheimer’s in development
• by Nov 5, 2021 05:24am

• Policy
• Gov needs to maintain patient benefits to the public
• by Lee, Jeong-Hwan Nov 5, 2021 05:23am